SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-574955
Filing Date
2016-05-03
Accepted
2016-05-03 16:12:56
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d184162d10q.htm 10-Q 530472
2 EX-31.1 d184162dex311.htm EX-31.1 8495
3 EX-31.2 d184162dex312.htm EX-31.2 8537
4 EX-32.1 d184162dex321.htm EX-32.1 3897
5 EX-32.2 d184162dex322.htm EX-32.2 3912
  Complete submission text file 0001193125-16-574955.txt   2459323

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT achn-20160331.xml EX-101.INS 277791
7 XBRL TAXONOMY EXTENSION SCHEMA achn-20160331.xsd EX-101.SCH 32206
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20160331_cal.xml EX-101.CAL 42858
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achn-20160331_def.xml EX-101.DEF 195440
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20160331_lab.xml EX-101.LAB 258913
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20160331_pre.xml EX-101.PRE 229828
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33095 | Film No.: 161615592
SIC: 2834 Pharmaceutical Preparations